We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a crossover randomised controlled trial to evaluate your digital health product.
An innovation competition aiming to accelerate commercialisation of innovative longer duration energy storage projects.
A speech by Sarah Cardell, CEO of the Competition and Markets Authority (CMA), delivered at the CMA's 10 year anniversary event.
A study of the impacts of long duration electricity storage technologies on the GB power system.
Employment Tribunal decision
New 10-year plan to expand and improve the drug and alcohol workforce published.
First published during the 2022 to 2024 Sunak Conservative government
Employment Tribunal decision.
We're consulting on the policy framework to enable investment in long duration electricity storage.
UK Semiconductor Institute announced to support key components of the government’s Semiconductor Strategy.
At the Farmers Weekly Transition Live Event, Environment Secretary Steve Barclay gave a speech outlining the support available from government for farmers
Explanation of vote by Ambassador Barbara Woodward on the General Assembly resolution on Palestinian UN membership, rights and privileges.
The British High Commission in Yaounde is accepting bids by 19 July 2024 for the UK’s International Programme Fund for the 2024 to 2025 financial year.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).